Paloma Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,643
| Closed | -$238K | – | 1195 |
|
|
2024
Q2 | $238K | Buy |
+14,643
| New | +$238K | 0.01% | 554 |
|
|
2021
Q2 | – | Sell |
-12,800
| Closed | -$148K | – | 1965 |
|
|
2021
Q1 | $148K | Buy |
+12,800
| New | +$148K | ﹤0.01% | 1657 |
|
|
2020
Q4 | – | Sell |
-195,000
| Closed | -$1.76M | – | 1927 |
|
|
2020
Q3 | $1.76M | Buy |
+195,000
| New | +$1.76M | 0.04% | 363 |
|
|
2019
Q4 | – | Sell |
-19,623
| Closed | -$135K | – | 2085 |
|
|
2019
Q3 | $135K | Buy |
+19,623
| New | +$135K | ﹤0.01% | 1483 |
|
|
2017
Q4 | – | Sell |
-12,663
| Closed | -$223K | – | 1588 |
|
|
2017
Q3 | $223K | Buy |
+12,663
| New | +$223K | ﹤0.01% | 1348 |
|
|
2017
Q1 | – | Sell |
-22,038
| Closed | -$798K | – | 1679 |
|
|
2016
Q4 | $798K | Buy |
22,038
+8,003
| +57% | +$290K | 0.01% | 877 |
|
|
2016
Q3 | $646K | Buy |
+14,035
| New | +$646K | 0.01% | 835 |
|
|
2016
Q2 | – | Sell |
-23,163
| Closed | -$1.24M | – | 1876 |
|
|
2016
Q1 | $1.24M | Buy |
23,163
+14,739
| +175% | +$788K | 0.02% | 483 |
|
|
2015
Q4 | $553K | Sell |
8,424
-6,111
| -42% | -$401K | 0.01% | 686 |
|
|
2015
Q3 | $821K | Buy |
14,535
+7,998
| +122% | +$452K | 0.02% | 513 |
|
|
2015
Q2 | $386K | Buy |
+6,537
| New | +$386K | 0.01% | 1002 |
|
|
2015
Q1 | – | Sell |
-11,600
| Closed | -$667K | – | 1290 |
|
|
2014
Q4 | $667K | Sell |
11,600
-29,300
| -72% | -$1.68M | 0.03% | 482 |
|
|
2014
Q3 | $2.2M | Buy |
40,900
+5,550
| +16% | +$298K | 0.1% | 177 |
|
|
2014
Q2 | $1.85M | Hold |
35,350
| – | – | 0.08% | 208 |
|
|
2014
Q1 | $1.87M | Buy |
35,350
+13,190
| +60% | +$697K | 0.12% | 133 |
|
|
2013
Q4 | $888K | Buy |
22,160
+7,110
| +47% | +$285K | 0.04% | 407 |
|
|
2013
Q3 | $569K | Sell |
15,050
-5,292
| -26% | -$200K | 0.02% | 452 |
|
|
2013
Q2 | $797K | Buy |
+20,342
| New | +$797K | 0.04% | 300 |
|